This disclosure provides multifunctional conjugate molecules in which at least one β-lactam antibiotic is covalently attached to a cannabinoid by means of a linker. The disclosed conjugate molecules are designed to deliver therapeutic benefits as intact molecules, with release of the cannabinoid upon binding of the β-lactam antibiotic to its target conveying further therapeutic benefits, and can be used to treat bacterial infections and other disorders.

This disclosure provides multifunctional conjugate molecules in which at least one β-lactam antibiotic is covalently attached to a cannabinoid by means of a linker. The disclosed conjugate molecules are designed to deliver therapeutic benefits as intact molecules, with release of the cannabinoid upon binding of the β-lactam antibiotic to its target conveying further therapeutic benefits, and can be used to treat bacterial infections and other disorders.

This disclosure provides multifunctional conjugate molecules in which at least one -lactam antibiotic is covalently attached to a cannabinoid by means of a linker. The disclosed conjugate molecules are designed to deliver therapeutic benefits as intact molecules, with release of the cannabinoid upon binding of the -lactam antibiotic to its target conveying further therapeutic benefits, and can be used to treat bacterial infections and other disorders.

This disclosure provides multifunctional conjugate molecules in which at least one -lactam antibiotic is covalently attached to a cannabinoid by means of a linker. The disclosed conjugate molecules are designed to deliver therapeutic benefits as intact molecules, with release of the cannabinoid upon binding of the -lactam antibiotic to its target conveying further therapeutic benefits, and can be used to treat bacterial infections and other disorders.

This disclosure provides multifunctional conjugate molecules in which at least one -lactam antibiotic is covalently attached to a cannabinoid by means of a linker. The disclosed conjugate molecules are designed to deliver therapeutic benefits as intact molecules, with release of the cannabinoid upon binding of the -lactam antibiotic to its target conveying further therapeutic benefits, and can be used to treat bacterial infections and other disorders.

This disclosure provides multifunctional conjugate molecules in which at least one -lactam antibiotic is covalently attached to a cannabinoid by means of a linker. The disclosed conjugate molecules are designed to deliver therapeutic benefits as intact molecules, with release of the cannabinoid upon binding of the -lactam antibiotic to its target conveying further therapeutic benefits, and can be used to treat bacterial infections and other disorders.